UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Yuhan’s Lazertinib promising as 1st-line therapy for NSCLC’
Expectations are rising for Lazertinib, an investigational drug that Yuhan ...
by Jeong Sae-im
|
2019-06-18 14:43
라인
LEO Pharma Korea names new CEO
LEO Pharma Korea said Tuesday it appointed Shin Jung-beom as its new chief ...
by Lee Han-soo
|
2019-06-18 14:36
라인
SK Biopharmaceutical's sleepiness treatment commercially available in US
Jazz Pharmaceuticals, SK Biopharmaceutical's U.S. partner, announced th...
by Lee Han-soo
|
2019-06-18 13:42
라인
Korean biosimilars take on original drugs in Europe
Korean biosimilars are threatening original drugs with improved competitive...
by Jeong Sae-im
|
2019-06-17 15:26
라인
AstraZeneca to invest $630 million in Korean biohealth sector
AstraZeneca said it would invest $630 million into Korea’s biotech and heal...
by Kim Yun-mi
|
2019-06-17 11:33
라인
Daewoong to develop hearing loss treatment using ion-channel platform tech
Daewoong Pharmaceutical said that it has signed a contract with Yonsei Univ...
by Lee Han-soo
|
2019-06-14 17:27
라인
Lilly, AbbVie unveil new data for psoriasis treatment at global meet
Lilly and AbbVie have presented new data regarding their psoriasis treatmen...
by Lee Han-soo
|
2019-06-14 14:26
라인
LSK Global PS wins international recognition in clinical data management
LSK Global PS said it has obtained an international certification for clini...
by Lee Hye-seon
|
2019-06-13 14:30
라인
‘Many drugs won Chinese approval without review suspension’
Korean botulinum toxin maker Medytox is likely to face a delay in winning C...
by Jeong Sae-im
|
2019-06-13 11:26
라인
Daewoong’s botulinum toxin hits a snag in European approval
Daewoong Pharmaceutical is expected to face a delay in obtaining European a...
by Jeong Sae-im
|
2019-06-12 16:50
라인
Novo Nordisk’s Saxenda dominates local obesity market
Novo Nordisk's Saxenda (ingredient: liraglutide), the world's first...
by Lee Han-soo
|
2019-06-12 14:16
라인
Forxiga prevents kidney disease in diabetes patients
AstraZeneca’s sodium-glucose cotransporter-2 (SGLT2) inhibitor Forxiga (ing...
by Kim Yun-mi
|
2019-06-11 15:40
라인
‘Medytox got review suspension in China only once’
Korean botulinum toxin maker Medytox said the Chinese regulator ordered the...
by Jeong Sae-im
|
2019-06-11 10:50
라인
[ASCO 2019] Imfinzi 1st IO to report 3-year OS in unresectable stage III NSCLC
Chicago, Ill -- AstraZeneca‘s Imfinzi (Ingredient: durvalumab) has demonstr...
by Lee Han-soo, KBR Correspondent
|
2019-06-11 08:00
라인
SCM, T&R to develop tissue regeneration, therapy products
SCM Life Science and T&R Biofab have agreed to collaborate on the research ...
by Lee Han-soo
|
2019-06-10 17:50
라인
Regulator OKs AstraZeneca's Fasenra as additional therapy for severe asthma
AstraZeneca's Fasenra (ingredient: benralizumab) gained approval as an ...
by Lee Han-soo
|
2019-06-10 17:10
라인
CJ HealthCare to invest ₩100 billion in new IV fluid factory
CJ HealthCare, a subsidiary of Kolmar Korea, said Monday it would invest 10...
by Jeong Sae-im
|
2019-06-10 16:17
라인
Hanmi unveils strong pipeline candidates in US diabetes meet
Hanmi Pharmaceutical said that it has confirmed its global competitiveness ...
by Lee Han-soo
|
2019-06-10 15:07
라인
Medytox’ botulinum toxin may face approval delay in China
Korean botulinum toxin maker Medytox may likely suffer a delay in Chinese r...
by Jeong Sae-im
|
2019-06-10 13:55
라인
Daewoong joins fray to develop rheumatoid arthritis drug
Daewoong Pharmaceutical said it has begun developing a rheumatoid arthritis...
by Lee Hye-seon
|
2019-06-07 11:29
-
이전
41
42
43
44
45
46
47
48
49
50
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top